19-28z CAR T cells: Phase II resumed

Juno said that FDA lifted a clinical hold on the open-label, U.S. Phase II ROCKET trial evaluating IV JCAR015. FDA placed

Read the full 216 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE